Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative propranolol and etodolac for resectable pancreatic cancer surgery
MOH_2018-03-12_002226Phase 2Not yet recruiting
- Sponsor
- פרופסור עודד זמורה
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of propranolol and etodolac in pancreatic cancer (PC), sponsored by פרופסור עודד זמורה. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
propranololetodolac
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on MOH_2018-03-12_002226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-03-12_002226.